Rural Pancreatic Cancer Treatment Gains Ground with FDA-Approved Daraxonrasib Program
A new clinical program involving the investigational drug daraxonrasib aims to improve access to pancreatic cancer treatment for rural patients. While the drug remains in clinical development and lacks full ... Read More